Back to the NewsWire

Intellectia Ai

Published September 4, 2026 · Updated September 6, 2026

Clearmind Medicine initiates Phase IIa trial for AUD treatment - Intellectia AI

Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic.

Read the full story at Intellectia Ai

Surfaced by this Google Alert

  • Psychedelic biotech